Browse by Audience
Skip to content
Papers of the Week
Adverse Events among Young Adults following a Third Dose of Measles-Mumps-Rubella Vaccine.
Authors
Abstract
A third measles-mumps-rubella vaccine (MMR) dose (MMR3) is recommended in the United States for persons at increased risk for mumps during outbreaks. MMR3 is also likely given to persons who might have received two doses of MMR but lack documentation. Since MMR3 safety data are limited, we describe adverse events in persons receiving MMR3 in a non-outbreak setting.